Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. Stock
  3. BOC
BOC logo

BOC Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Boston Omaha Corp (BOC) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
12.350
1 Day change
-0.56%
52 Week Range
15.750
Analysis Updated At
2026/03/06
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Boston Omaha Corp (BOC) is not a strong buy at the moment for a beginner investor with a long-term strategy. The stock lacks significant positive catalysts, has limited trading signals, and its financial performance, while improving, still shows negative net income and EPS. Additionally, the technical indicators are neutral, and there are no recent news or influential trades to drive momentum.

Technical Analysis

The MACD is slightly positive at 0.08, but contracting, indicating weakening momentum. RSI is neutral at 67.725, and moving averages are converging, providing no clear trend. The stock is trading near its pivot level of 12.529, with resistance at 12.942 and support at 12.116. Overall, technical indicators suggest a neutral trend.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
7
Buy
3

Positive Catalysts

  • Net income improved by 62.24% YoY, and EPS rose by 60.00% YoY, indicating some financial recovery.

Neutral/Negative Catalysts

  • Gross margin dropped by 5.60% YoY, and the company still reports negative net income and EPS. No recent news, insider activity, or congress trading data to drive sentiment. The stock has a projected negative trend over the next week (-2.14%) and month (-5.98%).

Financial Performance

In Q3 2025, revenue grew to $28.73 million (+3.73% YoY), net income improved to -$2.59 million (+62.24% YoY), and EPS increased to -0.08 (+60.00% YoY). However, gross margin declined to 44.35% (-5.60% YoY), and profitability remains negative.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst rating or price target data available for BOC.

Wall Street analysts forecast BOC stock price to rise
1 Analyst Rating
Wall Street analysts forecast BOC stock price to rise
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 12.420
sliders
Low
20
Averages
20
High
20
Current: 12.420
sliders
Low
20
Averages
20
High
20
TD Cowen
Buy
downgrade
$25 -> $22
AI Analysis
2025-08-20
Reason
TD Cowen
Price Target
$25 -> $22
AI Analysis
2025-08-20
downgrade
Buy
Reason
TD Cowen lowered the firm's price target on Boston Omaha to $22 from $25 and keeps a Buy rating on the shares. The firm said Boston Omaha's 2Q results fell short of expectations, with insurance weighed down by a higher loss ratio and reserve additions as a percentage of earned premium. They reduced 2H billboard and insurance estimates.
TD Cowen
Lance Vitanza
Strong Buy
Maintains
$28 → $25
2025-04-09
Reason
TD Cowen
Lance Vitanza
Price Target
$28 → $25
2025-04-09
Maintains
Strong Buy
Reason

People Also Watch